64950-359 : Goprelto 40 mg/ml Nasal Solution

Labeler: Genus Lifesciences Inc.
Product Type: Human Prescription Drug
Drug Name:  Goprelto
Dosage Form: Nasal Solution
Application #: NDA209963
Rev. Date: 
CSA Schedule: CII (US) [1]

NDC 64950-359 QR Code

[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

NDC Package Codes:

  • 64950-359-04: 1 BOTTLE, GLASS IN 1 CARTON (64950‑359‑04) > 4 ML IN 1 BOTTLE, GLASS

Active Ingredients:

  • Cocaine Hydrochloride

Dosage Strength:

  • 40 mg/mL
< Prev: 64950-354Next: 64950-362 >

Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 January 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA